Showing results (81-90 of 106) with videos related to
Sort By:
Pageof 11
Hepatology Communications|September 12, 2021
Longitudinal Analysis of the Utility of Liver Biochemistry as Prognostic Markers in Hospitalized Patients With Corona Virus Disease 2019Tingyan Wang, David A Smith, Cori Campbell, et al.Journal of Hematology & Oncology|March 23, 2017
A first-in-human phase 1 study of a hepcidin monoclonal antibody, LY2787106, in cancer-associated anemiaSaroj Vadhan-Raj, Rafat Abonour, Jonathan W Goldman, et al.Nature Communications|October 21, 2021
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failureDavid A Smith, Carlota Fernandez-Antunez, Andrea Magri, et al.BMC Infectious Diseases|June 27, 2021
Hepatitis B virus (HBV) viral load, liver and renal function in adults treated with tenofovir disoproxil fumarate (TDF) vs. untreated: a retrospective longitudinal UK cohort studyTingyan Wang, David A Smith, Cori Campbell, et al.Nano Letters|October 21, 2020
Element-Specific Detection of Sub-Nanosecond Spin-Transfer Torque in a Nanomagnet EnsembleSatoru Emori, Christoph Klewe, Jan-Michael Schmalhorst, et al.JIMD Reports|November 18, 2020
Defective platelet function in Niemann-Pick disease type C1Oscar C W Chen, Alexandria Colaco, Lianne C Davis, et al.The Journal of Infection|May 4, 2020
Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohortTongai G Maponga, Anna L McNaughton, Marije van Schalkwyk, et al.Wellcome Open Research|December 7, 2020
Bimodal distribution and set point HBV DNA viral loads in chronic infection: retrospective analysis of cohorts from the UK and South AfricaLouise O Downs, Sabeehah Vawda, Phillip Armand Bester, et al.Investigational New Drugs|September 28, 2014
An innovative, multi-arm, complete phase 1b study of the novel anti-cancer agent tasisulam in patients with advanced solid tumorsRobert M Jotte, Daniel D Von Hoff, Fadi Braiteh, et al.Frontiers in Oncology|August 9, 2018
nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLCCorey J Langer, Edward S Kim, Eric C Anderson, et al.Pageof 11